Accelerating Cancer Therapeutics (ACT)

Cancer therapeutic development accelerator program with the goal of advancing cancer therapies from the lab to the clinic; annual TRx pilot award and boot camp are designed to provide resources to develop a commercially relevant targeted product profile and meet targeted 12-month milestones. 

Sponsoring Entities: Herbert Irving Comprehensive Cancer Center, CUMC


Contact: Emer Smyth,